Laura Hix Glickman - Concepedia

Author

Laura Hix Glickman

Aduro BioTech (United States)

Also Known As

Basil Horst, Laura Glickman, Laura H. Glickman, Laura Hix Glickman, Laura Hix Glickman

Publications

Citations

H-Index

Concepts

All Affiliations

Aduro BioTech (United States)Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University Genomics Institute of the Novartis Research Foundation Tempest Technologies (United States)

About

Laura Hix Glickman is an author at Aduro BioTech (United States) specializing in tumor biology, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	110
2	Cell Biology	2	2	110
3	Immunology	1	1	11
4	Autoimmunity	1	1	11
5	Cancer Therapeutics	1	1	99

Laura Hix Glickman

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter, Cell Reports	2015	1.4K
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade Juan Fu, David B. Kanne, Meredith L. Leong, Science Translational Medicine	2015	681
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman, Cell Reports	2018	417
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer Heather Kinkead, Alexander C. Hopkins, Eric R. Lutz, JCI Insight	2018	152
NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice Madhavi Puchalapalli, Xianke Zeng, Liang Mu, PLoS ONE Breast Cancer MetastasisNsg Mice ProvideBreast Cancer GrowthBreast OncologyOncology	2016	99
TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors Brian J. Francica, Ali Ghasemzadeh, Anthony L. Desbien, Cancer Immunology Research	2018	83
Cyclic Dinucleotide–Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses Diego A. Espinosa, P. Robert Beatty, Gabrielle L. Reiner, The Journal of Immunology	2019	33
Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity Laura Hix Glickman, David B. Kanne, Shailaja Kasibhatla, Cancer Research Abstract StimulatorInnate Immune SystemImmunologyImmune RegulationImmunoediting	2016	11

Page 1